miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance

Refractory disease and relapse remain the main causes of cancer therapy failure. Refined risk stratification, treatment regimens and improved early diagnosis and detection of minimal residual disease have increased cure rates in malignancies like childhood acute lymphoblastic leukaemia (ALL) to 90%....

Descripción completa

Detalles Bibliográficos
Autores principales: Sbirkov, Yordan, Vergov, Bozhidar, Mehterov, Nikolay, Sarafian, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103677/
https://www.ncbi.nlm.nih.gov/pubmed/35563051
http://dx.doi.org/10.3390/ijms23094657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103677/
https://www.ncbi.nlm.nih.gov/pubmed/35563051
http://dx.doi.org/10.3390/ijms23094657

Ejemplares similares